These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32186786)

  • 21. Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies.
    Yakoubi R; Colin P; Seisen T; Léon P; Nison L; Bozzini G; Shariat SF; Rouprêt M
    Eur J Surg Oncol; 2014 Dec; 40(12):1629-34. PubMed ID: 25108813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation Between Confocal Laser Endomicroscopy (Cellvizio
    Breda A; Territo A; Guttilla A; Sanguedolce F; Manfredi M; Quaresima L; Gaya JM; Algaba F; Palou J; Villavicencio H
    Eur Urol Focus; 2018 Dec; 4(6):954-959. PubMed ID: 28753800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience.
    Motamedinia P; Keheila M; Leavitt DA; Rastinehad AR; Okeke Z; Smith AD
    J Endourol; 2016 Mar; 30(3):262-7. PubMed ID: 26630130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions.
    De Groote R; Decaestecker K; Larcher A; Buelens S; De Bleser E; D'Hondt F; Schatteman P; Lumen N; Montorsi F; Mottrie A; De Naeyer G;
    J Robot Surg; 2020 Feb; 14(1):211-219. PubMed ID: 31041588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma: Oncologic Outcomes and Prognostic Factors in a Contemporary Cohort.
    Sanguedolce F; Fontana M; Turco M; Territo A; Lucena JB; Cortez JC; Vanacore D; Meneghetti I; Gallioli A; Gaya JM; Redorta JP; Breda A
    J Endourol; 2021 Nov; 35(11):1593-1600. PubMed ID: 33971725
    [No Abstract]   [Full Text] [Related]  

  • 27. Abnormal selective cytology results predict recurrence of upper-tract transitional-cell carcinoma treated with ureteroscopic laser ablation.
    Boorjian S; Ng C; Munver R; Palese MA; Sosa RE; Vaughan ED; Del Pizzo JJ; Scherr DS
    J Endourol; 2004 Nov; 18(9):912-6. PubMed ID: 15659932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrograde endoscopic laser therapy for transitional cell carcinoma of the upper urinary tract.
    Mugiya S; Maruyama S; Nagata M; Hadano S; Nagae H
    Int J Urol; 2003 Jul; 10(7):371-6. PubMed ID: 12823691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which Patients with Upper Tract Urothelial Carcinoma Can be Safely Treated with Flexible Ureteroscopy with Holmium:YAG Laser Photoablation? Long-Term Results from a High Volume Institution.
    Villa L; Haddad M; Capitanio U; Somani BK; Cloutier J; Doizi S; Salonia A; Briganti A; Montorsi F; Traxer O
    J Urol; 2018 Jan; 199(1):66-73. PubMed ID: 28818526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma.
    Meng X; Chao B; Vijay V; Silver H; Margolin EJ; Balar A; Taneja SS; Shah O; Bjurlin MA; Anderson CB; Huang WC
    Urology; 2019 Jul; 129():146-152. PubMed ID: 30930207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transurethral flexible ureteroscopic holmium laser resection for tumors of renal pelvis: 6 cases report and literature review].
    Hao YC; Chen K; Liu YQ; Lu J; Xiao CL; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):816-821. PubMed ID: 30337741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
    Goel MC; Mahendra V; Roberts JG
    J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology.
    Roberts JL; Ghali F; Aganovic L; Bechis S; Healy K; Rivera-Sanfeliz G; Autorino R; Derweesh I
    Abdom Radiol (NY); 2019 Dec; 44(12):3893-3905. PubMed ID: 31701194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.
    Gakis G; Schubert T; Alemozaffar M; Bellmunt J; Bochner BH; Boorjian SA; Daneshmand S; Huang WC; Kondo T; Konety BR; Laguna MP; Matin SF; Siefker-Radtke AO; Shariat SF; Stenzl A
    World J Urol; 2017 Mar; 35(3):327-335. PubMed ID: 27043218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens].
    Wang Y; He HY
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):681-686. PubMed ID: 27760608
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
    Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variant isoforms of CD44 expression in upper tract urothelial cancer as a predictive marker for recurrence and mortality.
    Hagiwara M; Kikuchi E; Kosaka T; Mikami S; Saya H; Oya M
    Urol Oncol; 2016 Aug; 34(8):337.e19-26. PubMed ID: 27133224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic Treatment of Upper Tract Urothelial Carcinoma.
    Verges DP; Lallas CD; Hubosky SG; Bagley DH
    Curr Urol Rep; 2017 Apr; 18(4):31. PubMed ID: 28251485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma.
    Samson P; Smith AD; Hoenig D; Okeke Z
    J Endourol; 2018 May; 32(S1):S10-S16. PubMed ID: 29774823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.